Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more
Mediantechn (ALMDT) - Net Assets
Latest net assets as of June 2025: €-40.47 Million EUR
Based on the latest financial reports, Mediantechn (ALMDT) has net assets worth €-40.47 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€19.43 Million) and total liabilities (€59.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-40.47 Million |
| % of Total Assets | -208.29% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -229.43% |
| Growth Volatility | 303.71 |
Mediantechn - Net Assets Trend (2008–2024)
This chart illustrates how Mediantechn's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mediantechn (2008–2024)
The table below shows the annual net assets of Mediantechn from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-33.97 Million | -230.00% |
| 2023-12-31 | €-10.29 Million | -41.91% |
| 2022-12-31 | €-7.25 Million | -246.85% |
| 2021-12-31 | €4.94 Million | +143.47% |
| 2020-12-31 | €-11.36 Million | -986.96% |
| 2019-12-31 | €1.28 Million | -85.91% |
| 2018-12-31 | €9.09 Million | -63.54% |
| 2017-12-31 | €24.94 Million | -35.62% |
| 2016-12-31 | €38.74 Million | +47.61% |
| 2015-12-31 | €26.24 Million | +90.50% |
| 2014-12-31 | €13.78 Million | -- |
| 2013-12-31 | €0.00 | -- |
| 2012-12-31 | €0.00 | -- |
| 2011-12-31 | €5.06 Million | +290.17% |
| 2010-12-31 | €-2.66 Million | -470.90% |
| 2009-12-31 | €717.62K | -83.56% |
| 2008-12-31 | €4.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mediantechn's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1338793200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €926.00K | % |
| Other Comprehensive Income | €-107.28 Million | % |
| Other Components | €97.63 Million | % |
| Total Equity | €-33.97 Million | 100.00% |
Mediantechn Competitors by Market Cap
The table below lists competitors of Mediantechn ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hurco Companies Inc
NASDAQ:HURC
|
$86.94 Million |
|
Han Shin Mach
KO:011700
|
$87.00 Million |
|
SK Growth Opportunities Corporation
NASDAQ:SKGR
|
$87.04 Million |
|
Sejong Industrial
KO:033530
|
$87.06 Million |
|
Bestsun Energy Co Ltd
SHG:600681
|
$86.89 Million |
|
ODFJELL TECHNOLOGYLTD
F:ND4
|
$86.88 Million |
|
WiSoL CO.LTD
KQ:122990
|
$86.86 Million |
|
COGELEC S.A. EO-45
F:5TL
|
$86.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mediantechn's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -10,294,000 to -33,967,000, a change of -23,673,000.
- Net loss of 25,240,000 reduced equity.
- Share repurchases of 40,000 reduced equity.
- New share issuances of 67,000 increased equity.
- Other comprehensive income decreased equity by 21,697,000.
- Other factors increased equity by 23,237,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-25.24 Million | -74.31% |
| Share Repurchases | €40.00K | -0.12% |
| Share Issuances | €67.00K | +0.2% |
| Other Comprehensive Income | €-21.70 Million | -63.88% |
| Other Changes | €23.24 Million | +68.41% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Mediantechn's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | €0.65 | €4.85 | x |
| 2009-12-31 | €0.13 | €4.85 | x |
| 2010-12-31 | €-0.48 | €4.85 | x |
| 2011-12-31 | €0.87 | €4.85 | x |
| 2012-12-31 | €0.31 | €4.85 | x |
| 2013-12-31 | €-0.18 | €4.85 | x |
| 2014-12-31 | €1.24 | €4.85 | x |
| 2015-12-31 | €2.05 | €4.85 | x |
| 2016-12-31 | €2.82 | €4.85 | x |
| 2017-12-31 | €1.83 | €4.85 | x |
| 2018-12-31 | €0.68 | €4.85 | x |
| 2019-12-31 | €0.11 | €4.85 | x |
| 2020-12-31 | €-0.94 | €4.85 | x |
| 2021-12-31 | €0.32 | €4.85 | x |
| 2022-12-31 | €-0.46 | €4.85 | x |
| 2023-12-31 | €-0.56 | €4.85 | x |
| 2024-12-31 | €-1.84 | €4.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mediantechn utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -109.99%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-130.77%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -101.77% | -254.81% | 0.25x | 1.60x | €-4.06 Million |
| 2009 | -499.30% | -311.19% | 0.23x | 7.00x | €-3.65 Million |
| 2010 | 0.00% | -295.09% | 0.25x | 0.00x | €-3.11 Million |
| 2011 | -72.12% | -492.30% | 0.07x | 2.07x | €-4.16 Million |
| 2012 | -218.95% | -448.74% | 1.81x | 0.27x | €-4.16 Million |
| 2013 | 0.00% | -361.48% | 2.88x | 0.00x | €-4.24 Million |
| 2014 | -35.16% | -147.59% | 0.18x | 1.30x | €-6.22 Million |
| 2015 | -21.06% | -142.27% | 0.12x | 1.28x | €-8.15 Million |
| 2016 | -23.52% | -143.39% | 0.14x | 1.20x | €-12.98 Million |
| 2017 | -69.00% | -223.86% | 0.23x | 1.37x | €-19.70 Million |
| 2018 | -168.09% | -241.07% | 0.35x | 2.00x | €-16.19 Million |
| 2019 | -623.58% | -89.24% | 0.56x | 12.58x | €-8.12 Million |
| 2020 | 0.00% | -94.97% | 0.53x | 0.00x | €-11.66 Million |
| 2021 | -390.61% | -93.89% | 0.42x | 10.00x | €-19.79 Million |
| 2022 | 0.00% | -85.40% | 0.68x | 0.00x | €-19.49 Million |
| 2023 | 0.00% | -103.40% | 0.62x | 0.00x | €-21.95 Million |
| 2024 | 0.00% | -109.99% | 0.94x | 0.00x | €-21.84 Million |
Industry Comparison
This section compares Mediantechn's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $37,172,990
- Average return on equity (ROE) among peers: -36.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mediantechn (ALMDT) | €-40.47 Million | -101.77% | N/A | $86.92 Million |
| Affluent Medical SAS (AFME) | $33.83 Million | -45.01% | 0.77x | $31.64 Million |
| Biosynex (ALBIO) | $124.31 Million | -29.72% | 0.94x | $7.06 Million |
| Bluelinea SA (ALBLU) | $1.96 Million | -41.72% | 0.71x | $6.02 Million |
| Carmat (ALCAR) | $-43.76 Million | 0.00% | 0.00x | $3.28 Million |
| Diagnostic Medical Systems SA (ALDMS) | $13.72 Million | -36.04% | 2.73x | $13.39 Million |
| Eurobio Scientific SA (ALERS) | $175.17 Million | 2.76% | 0.81x | $5.52 Million |
| Ikonisys SA (ALIKO) | $20.01 Million | -2.85% | 0.13x | $9.76 Million |
| Implanet SA (ALIMP) | $3.54 Million | -99.97% | 3.09x | $6.96 Million |
| Spineguard (ALSGD) | $5.77 Million | -78.70% | 0.48x | $5.70 Million |